DexCom
DXCM
YETI Holdings
YETI
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 54.505
- +1.265+2.38%
Trading Jan 3 13:41 ET
3.20BMarket Cap-46.59P/E (TTM)
54.540High52.520Low276.91KVolume53.600Open53.240Pre Close14.91MTurnover0.63%Turnover RatioLossP/E (Static)58.63MShares71.71052wk High4.87P/B2.41BFloat Cap7.79052wk Low--Dividend TTM44.21MShs Float71.710Historical High--Div YieldTTM3.79%Amplitude5.650Historical Low53.852Avg Price1Lot Size
Janux Therapeutics News
Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 8-K: Current report
Janux Therapeutics | 424B5: Prospectus
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 424B5: Prospectus
Janux Therapeutics | 8-K: Current report
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Campbell, Ph.D.(4.8%)
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(2.0%),Citadel Advisors LLC(1.9%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(4.1%),Tighe Reardon(3.0%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L
Janux Therapeutics | 10-Q: Q3 2024 Earnings Report
Janux Therapeutics | 8-K: Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bregua Corporation(5.8%)